These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10310478)

  • 21. Financial tools in evaluating profit and DRG cost determination.
    Wilson CN
    Hosp Pharm; 1984 Jun; 19(6):438-9. PubMed ID: 10310618
    [No Abstract]   [Full Text] [Related]  

  • 22. Avoiding the DRG crunch.
    Tideiksaar R
    Physician Assist; 1984 Aug; 8(8):44, 46. PubMed ID: 10314596
    [No Abstract]   [Full Text] [Related]  

  • 23. Obtaining estimates of marginal cost by DRG.
    Bridges JM; Jacobs P
    Healthc Financ Manage; 1986 Oct; 40(10):40-6. PubMed ID: 10311667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DRG checklist.
    Weil TP
    South Hosp; 1984; 52(2):50, 52, 54 passim. PubMed ID: 10310484
    [No Abstract]   [Full Text] [Related]  

  • 25. Pressure sores: finding the facts.
    Trehane E
    Nurs Stand Spec Suppl; 1988 Dec; (2):4-6. PubMed ID: 3211219
    [No Abstract]   [Full Text] [Related]  

  • 26. DRG legislation and rheumatic disease.
    Lockshin MD
    Bull Rheum Dis; 1984; 34(4):1-5. PubMed ID: 6442177
    [No Abstract]   [Full Text] [Related]  

  • 27. DRG payments and net contribution variance analysis.
    Grimaldi PL
    Healthc Financ Manage; 1984 Feb; 38(2):14-5. PubMed ID: 10315495
    [No Abstract]   [Full Text] [Related]  

  • 28. Standard cost accounting: methods that can be applied to DRG classifications.
    Messmer VC
    Healthc Financ Manage; 1984 Jan; 38(1):44-5, 48. PubMed ID: 10315488
    [No Abstract]   [Full Text] [Related]  

  • 29. Coping with DRG cutbacks.
    Hosp Secur Saf Manage; 1984 Sep; 5(5):5-10. PubMed ID: 10310762
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis related groups: recent developments and their adaption and application in Australia.
    Palmer G; Wood T
    Aust Health Rev; 1984; 7(2):67-80. PubMed ID: 10310729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Many hospitals report success in cutting DRG 106, 107 costs.
    Nathanson M
    Mod Healthc; 1985 Feb; 15(4):82-4. PubMed ID: 10310992
    [No Abstract]   [Full Text] [Related]  

  • 32. DRG payments and net contribution variance analysis.
    Soliman SY; Hughes WL
    Healthc Financ Manage; 1983 Oct; 37(10):78-86. PubMed ID: 10315441
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of DRGs on devices and diagnostics.
    Clin Eng Inf Serv; 1984; 8(2):38-40. PubMed ID: 10310517
    [No Abstract]   [Full Text] [Related]  

  • 34. A smarter way to buy.
    Degraeve Z; Roodhooft F
    Harv Bus Rev; 2001 Jun; 79(6):22-3, 145. PubMed ID: 11408975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Many hospitals report problems cutting DRG 89 treatment costs.
    Punch L
    Mod Healthc; 1985 Feb; 15(4):76-8. PubMed ID: 10310991
    [No Abstract]   [Full Text] [Related]  

  • 36. Poor diagnosis, poor treatment. How the DRG system affects hospitals that serve the poor.
    Kotelchuck R
    Health PAC Bull; 1985; 16(1):7-13. PubMed ID: 10311123
    [No Abstract]   [Full Text] [Related]  

  • 37. DRG dumping?
    Mod Healthc; 1985 Mar; 15(6):5. PubMed ID: 10311029
    [No Abstract]   [Full Text] [Related]  

  • 38. Determining a contribution margin for DRG profitability.
    Kohlman HA
    Healthc Financ Manage; 1984 Apr; 38(4):108, 110. PubMed ID: 10315522
    [No Abstract]   [Full Text] [Related]  

  • 39. The DRG and the hospital's reaction.
    Wilson CN
    Hosp Pharm; 1984 Mar; 19(3):232, 234. PubMed ID: 10310551
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives. Is DRG creep spoiling the system?
    Sorian R
    Wash Rep Med Health; 1984 Sep; 38(35):suppl 4p. PubMed ID: 10310791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.